NCT04929093View on ClinicalTrials.gov

Novel Dose Adjustment Schedule for Late Injection in SCIT in AR

PHASE4CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

June 11, 2020

Primary Completion Date

April 16, 2021

Study Completion Date

April 30, 2021

Conditions
Allergic RhinitisImmunotherapy
Interventions
BIOLOGICAL

Novel dose adjustment of Alutard SQ

novel dose adjustment schedule means directly reaching dose of Vial 4, 10,000 SQ

BIOLOGICAL

conventional dose adjustment of Alutard SQ

conventional dose adjustment schedule means restarting from dose of Vial 1, 10 SQ

BIOLOGICAL

Routine continuous cluster of Alutard SQ

Patient receiving continuous cluster SCIT for DM during the same period

Trial Locations (1)

100730

Beijing Tongren Hospital, Beijing

All Listed Sponsors
lead

Beijing Tongren Hospital

OTHER

NCT04929093 - Novel Dose Adjustment Schedule for Late Injection in SCIT in AR | Biotech Hunter | Biotech Hunter